Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 1
1997 7
1998 13
1999 25
2000 21
2001 49
2002 48
2003 33
2004 53
2005 79
2006 70
2007 75
2008 78
2009 75
2010 68
2011 61
2012 65
2013 71
2014 72
2015 50
2016 43
2017 51
2018 54
2019 37
2020 34
2021 27
2022 26
2023 27
2024 23
2025 29
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,220 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean olterodine[All Fields] (1 results)?
Tolterodine.
Hills CJ, Winter SA, Balfour JA. Hills CJ, et al. Drugs. 1998 Jun;55(6):813-20; discussion 821-2. doi: 10.2165/00003495-199855060-00008. Drugs. 1998. PMID: 9617596 Review.
In comparative trials, tolterodine and oxybutynin are equivalent in terms of efficacy. However, tolterodine is significantly better tolerated than oxybutynin, particularly with respect to the incidence and severity of dry mouth. No clinically relevant ECG changes ha …
In comparative trials, tolterodine and oxybutynin are equivalent in terms of efficacy. However, tolterodine is significantly b …
Tolterodine: an overview.
Wefer J, Truss MC, Jonas U. Wefer J, et al. World J Urol. 2001 Nov;19(5):312-8. doi: 10.1007/s003450100224. World J Urol. 2001. PMID: 11760779 Review.
Tolterodine has emerged as a new anticholinergic drug to treat detrusor instability in recent years. ...A new extended release formula of tolterodine has been launched that may improve patients' compliance....
Tolterodine has emerged as a new anticholinergic drug to treat detrusor instability in recent years. ...A new extended release formul …
Tolterodine Tartrate.
Ananchenko G, Novakovic J. Ananchenko G, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:339-403. doi: 10.1016/bs.podrm.2017.02.007. Epub 2017 Mar 30. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431780
Tolterodine tartrate belongs to the family of muscarinic receptor antagonists and is indicated for the treatment of overactive urinary bladder syndrome. This chapter provides an overview of physical, analytical, and ADME profiles; highlights methods of chemical synt …
Tolterodine tartrate belongs to the family of muscarinic receptor antagonists and is indicated for the treatment of overactive …
Editorial comment.
Yang SS. Yang SS. J Urol. 2009 Oct;182(4 Suppl):2038-9; discussion 2039. doi: 10.1016/j.juro.2009.05.162. Epub 2009 Aug 20. J Urol. 2009. PMID: 19695625 No abstract available.
Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis.
Li S, Li P, Wang R, Li H. Li S, et al. Eur J Clin Pharmacol. 2022 Jun;78(6):897-906. doi: 10.1007/s00228-021-03251-5. Epub 2022 Feb 26. Eur J Clin Pharmacol. 2022. PMID: 35218404
Eleven drugs were investigated in more than two RCTs, of which dexmedetomidine, gabapentin, tolterodine, tramadol, ketamine, nefopam, oxybutynin, pregabalin, and pudendal nerve block (PNB) generally showed significantly higher efficacy than controls postoperatively. ...CON …
Eleven drugs were investigated in more than two RCTs, of which dexmedetomidine, gabapentin, tolterodine, tramadol, ketamine, nefopam, …
Editorial comment.
de Jong TP. de Jong TP. J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.160. Epub 2009 Aug 20. J Urol. 2009. PMID: 19695627 No abstract available.
Editorial comment.
Jorgensen TM. Jorgensen TM. J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.161. Epub 2009 Aug 20. J Urol. 2009. PMID: 19695626 No abstract available.
Fesoterodine fumarate.
Gomelsky A, Dmochowski RR. Gomelsky A, et al. Drugs Today (Barc). 2010 Feb;46(2):81-90. doi: 10.1358/dot.2010.46.2.1437712. Drugs Today (Barc). 2010. PMID: 20393636
The active metabolite, 5-hydroxymethyl tolterodine, is responsible for all of the antimuscarinic effects. In two phase III studies, fesoterodine has been shown to significantly reduce mean urgency and urge urinary incontinence (UUI) episodes over placebo. ...
The active metabolite, 5-hydroxymethyl tolterodine, is responsible for all of the antimuscarinic effects. In two phase III studies, f …
Tolterodine in the Treatment of Male LUTS.
Gacci M, Sebastianelli A, Salvi M, Schiavina R, Brunocilla E, Novara G, De Nunzio C, Tubaro A, Oelke M, Gravas S, Carini M, Serni S. Gacci M, et al. Curr Urol Rep. 2015 Sep;16(9):60. doi: 10.1007/s11934-015-0531-9. Curr Urol Rep. 2015. PMID: 26149965 Review.
In order to improve compliance with oral drug treatment, tolterodine was developed, providing a better efficacy/adverse event profile. Tolterodine is available in the following two formulations: the intermediate release (IR) and extended release form (ER). Tolter …
In order to improve compliance with oral drug treatment, tolterodine was developed, providing a better efficacy/adverse event profile …
Reply by Authors.
Ko KJ, Kim KH, Kim SW, Kim SO, Seo JT, Choo MS, Lee JZ, Oh SJ, Kim HG, Min KS, Kim JH, Lee KS. Ko KJ, et al. J Urol. 2019 Sep;202(3):572-573. doi: 10.1097/01.JU.0000558556.60504.cd. Epub 2019 Aug 8. J Urol. 2019. PMID: 31166885 No abstract available.
1,220 results